Medical Research
(H25)
IRS Verified
DX Registered
AMYLOIDOSIS FOUNDATION
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$535K
Total Revenue
$569K
Total Expenses
N/A
Net Assets
3
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$62K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $535K | $569K | N/A | — | 3 |
| 2022 | $710K | $598K | N/A | — | 3 |
| 2021 | $779K | $709K | N/A | — | 3 |
| 2020 | $694K | $592K | N/A | — | 3 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.